Progenics plans to conduct $50 million at-the-market equity offering

Offering was arranged with Cantor Fitzgerald as the selling agent

By Devika Patel

Knoxville, Tenn., Jan. 24 - Progenics Pharmaceuticals Inc. arranged a $50 million at-the-market equity offering with agent Cantor Fitzgerald & Co. on Jan. 23, according to an 8-K filed Friday with the Securities and Exchange Commission.

Cantor will be paid a 3% commission.

Progenics, based in Tarrytown, N.Y., is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.